Product NDC: | 0187-3554 |
Proprietary Name: | ANCOBON |
Non Proprietary Name: | Flucytosine |
Active Ingredient(s): | 250 mg/1 & nbsp; Flucytosine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0187-3554 |
Labeler Name: | Valeant Pharmaceuticals North America LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017001 |
Marketing Category: | NDA |
Start Marketing Date: | 19711126 |
Package NDC: | 0187-3554-10 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0187-3554-10) |
NDC Code | 0187-3554-10 |
Proprietary Name | ANCOBON |
Package Description | 100 CAPSULE in 1 BOTTLE (0187-3554-10) |
Product NDC | 0187-3554 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Flucytosine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19711126 |
Marketing Category Name | NDA |
Labeler Name | Valeant Pharmaceuticals North America LLC |
Substance Name | FLUCYTOSINE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antifungal [EPC] |